We are live on ! Find out more
TTPH

Tetraphase Pharmaceuticals
TTPH

Delisted

TTPH was delisted on the 28th of July, 2020.

41 hedge funds and large institutions have $56.8M invested in Tetraphase Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

39.08% more ownership

Funds ownership: 0% → 39.08% (+39%)

Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

TTPH Hedge Fund Activity: Q2 2013 in Review

41 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals (TTPH) for Q2 2013, worth a combined $56.8M.

Fund positioning in TTPH was balanced in Q2 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 41 institutional investors held Tetraphase Pharmaceuticals (TTPH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $56.8M of Tetraphase Pharmaceuticals stock for Q2 2013.
  • 0 funds opened new Tetraphase Pharmaceuticals positions in Q2 2013 and 0 closed out.

Based on aggregated 13F filings for Q2 2013.